Molecular Profiling of Advanced Refractory Prostate Cancer


Rebecca Feldman Ph.D. , Gargi Basu Ph.D. , Joanne Xiu Ph.D. , David Arguello M.D. , Sherri Z. Millis Ph.D. , Ryan Bender Ph.D. , Zoran Gatalica M.D. , Les Paul M.D. , Charles Myers M.D

Background: Prostate cancer is the second leading cause of cancer‐related death among men in the US. Forty percent of men diagnosed will develop metastatic disease which has few treatment options. We aim to describe the molecular profile of prostate cancer tumors and potential for novel therapeutic options.

Download Publication